Dr. Öğr. Üyesi Melis KARTAL YANDIM
Tıp Fakültesi
Temel Tıp Bilimleri
Dr. Öğr. Üyesi Melis KARTAL YANDIM
Tıp Fakültesi
Temel Tıp Bilimleri
MAKALELER
SCI, SSCI ve AHCI tarafından taranan dergilerde yayımlanmış veya kabul edilmiş makaleler
Ulusal
- N.Gül Amuk , G.Kurt , M.Kartal Yandim , A.Adan and Y.Baran.
(2018) A minimally invasive transfer method of mesenchymal stem cells to the intact periodontal ligament of rat teeth: A preliminary study.
Turkish Journal Of Biology , Vol. 42, No. 5, 382-391,
Uluslararası
- S.İsik , N.Uzuner , M.Karaman , O.Karaman , M.Kiray , I.Kozanoğlu , H.Bagriyanik , Z.Arikan Ayyildiz , M.Kartal Yandim and Y.Baran.
(2017) Effects of intraperitoneal injection of allogeneic bone marrow-derived mesenchymal stem cells on bronchiolitis obliterans in mice model.
Iranian Journal Of Allergy, Asthma And Immunology , Vol. 16, No. 3, 205-218,
- Y.Kiraz , A.Adan , M.Kartal Yandim , Y.Baran.
(2016) Major apoptotic mechanisms and genes involved in apoptosis.
Tumor Biology , Vol. 37, No. 7, 8471-8486,
- M.Kartal Yandim , A.Adan Gokbulut , Y.Baran.
(2016) Molecular mechanisms of drug resistance and its reversal in cancer.
Critical Reviews In Biotechnology , Vol. 36, No. 4, 716-726,
- M.Kartal Yandim , C.Ceylan , E.Elmas , Y.Baran.
(2016) A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib.
Tumor Biology , Vol. 37, No. 2, 2365-2378,
- N.G.Amuk , G.Kurt , Y.Baran , V.Seyrantepe , M.Kartal Yandim , A.Adan , S.Akyildiz Demir , Y.Kiraz , M.F.Sonmez.
(2016) Effects of cell-mediated osteoprotegerin gene transfer and mesenchymal stem cell applications on orthodontically induced root resorption of rat teeth.
European Journal Of Orthodontics ,
- O.Tufekci , M.Kartal Yandim , H.Oren , G.Irken , Y.Baran.
(2015) Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line.
Leukemia Research , Vol. 39, No. 3, 342-347,
- B.Tezcanli Kaymaz , N.Selvi Gunel , M.Ceyhan , V.Bozok Çetintaş , B.Özel , M.Kartal Yandim , S.Kipcak , C.Aktan , A.Adan Gökbulut , Y.Baran and C.BK.
(2015) Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
Vol. 36, No. 10, 7915-7927,
- M.Kartal Yandim , E.Apohan , Y.Baran.
(2013) Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Cancer Chemotherapy And Pharmacology , Vol. 71, No. 1, 13-20,
- A.Adan Gokbulut , M.Kartal Yandim , G.Iskender , Y.Baran.
(2013) Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Current Medicinal Chemistry , Vol. 20, No. 1, 108-122,
- I.Kozanoglu , M.Kartal Yandim , Z.Cincin , H.Ozdogu , B.Cakmakoglu , Y.Baran.
(2013) New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.
Journal Of Cancer Research And Clinical Oncology , Vol. 139, No. 2, 327-335,
- H.Kiper , B.Tezcanli Kaymaz , A.Adan Gokbulut , N.Selvi , C.Biray Avci , B.Kosova , G.Iskender , M.Kartal Yandim , C.Gunduz , F.Sahin , Y.Baran and G.Saydam.
(2013) STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells.
Biomedicine And Pharmacotherapy , Vol. 67, No. 6, 527-532,
- G.Can , Z.Cakir , M.Kartal , U.Gunduz , Y.Baran.
(2012) Apoptotic effects of resveratrol, a grape polyphenol, onimatinib-sensitive and resistant K562 chronic myeloid leukemia cells.
Anticancer Research , Vol. 32, No. 7, 2373-2678,
- C.Avci , S.Yilmaz , Z.Dogan , G.Saydam , Y.Dodurga , H.Ekiz , M.Kartal , F.Sahin , Y.Baran , C.Gunduz.
(2011) Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells.
Hematology , Vol. 16, No. 5, 303-307,
- M.Kartal , G.Saydam , F.Sahin , Y.Baran.
(2011) Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
Nutrition And Cancer , Vol. 63, No. 4, 637-644,
- B.Kosova , B.Tezcanli , H.Ekiz , Z.Cakir , N.Selvi , A.Dalmizrak , M.Kartal , U.Gunduz , Y.Baran.
(2010) Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells.
Leukemia And Lymphoma , Vol. 51, No. 10, 1895-1901,
Diğer indexler tarafından taranan dergilerde yayımlanmış veya kabul edilmiş makaleler
Ulusal
- O.Gokdemir , D.Ersil Soysal , H.Pak , M.Kartal Yandim , I.Semin .
(2023) Evaluation of Polypharmacy in Individuals over 65 Years of Age in Balcova District of Izmir-Short Report.
DAHUDER Medical Journal , Vol. 3, No. 2, 67-71,
- M.Kartal Yandım , M.Bilgin.
(2022) Shotgun Lipidomics Elucidates the Lipidome Alterations of the Mcl-1 Inhibitor S63845 in AML Cell Lines with a Focus on Sphingolipids.
Experimed , Vol. 12, No. 3, 209-214,
Uluslararası
- M.Kartal Yandim , I.Kozanoglu , H.Ozdogu , O.Piskin , M.A.Ozcan , G.Saydam , F.Sahin , F.Avcu , A.U.Ural , A.Unal , Y.Baran.
(2020) Novel biomarkers for tyrosine kinase inhibitor resistance in chronic myeloid leukemia patients: Bioactive sphingolipids.
Journal Of Hematology And Therapeutics , Vol. 2, No. 1, 1-7,